Lemaitre Vascular (LMAT) Misses Q3 EPS by 3c; Offers FY22 Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $39 million versus the consensus estimate of $40.06 million.

GUIDANCE:

Lemaitre Vascular sees FY2022 EPS of $1.02-$1.08, versus the consensus of $1.09. Lemaitre Vascular sees FY2022 revenue of $160.5-162.9 million, versus the consensus of $163.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)